Cite
Bar-Or A, Wiendl H, Montalban X, et al. Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study. Mult Scler. 2021;13524585211044479doi: 10.1177/13524585211044479.
Bar-Or, A., Wiendl, H., Montalban, X., Alvarez, E., Davydovskaya, M., Delgado, S. R., Evdoshenko, E. P., Giedraitiene, N., Gross-Paju, K., Haldre, S., Herrman, C. E., Izquierdo, G., Karelis, G., Leutmezer, F., Mares, M., Meca-Lallana, J. E., Mickeviciene, D., Nicholas, J., Robertson, D. S., Sazonov, D. V., Sharlin, K., Sundaram, B., Totolyan, N., Vachova, M., Valis, M., Bagger, M., Häring, D. A., Ludwig, I., Willi, R., Zalesak, M., Su, W., Merschhemke, M., & Fox, E. J. (2021). Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study. Multiple sclerosis (Houndmills, Basingstoke, England), 13524585211044479. https://doi.org/10.1177/13524585211044479
Bar-Or, Amit, et al. "Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study." Multiple sclerosis (Houndmills, Basingstoke, England) vol. (2021): 13524585211044479. doi: https://doi.org/10.1177/13524585211044479
Bar-Or A, Wiendl H, Montalban X, Alvarez E, Davydovskaya M, Delgado SR, Evdoshenko EP, Giedraitiene N, Gross-Paju K, Haldre S, Herrman CE, Izquierdo G, Karelis G, Leutmezer F, Mares M, Meca-Lallana JE, Mickeviciene D, Nicholas J, Robertson DS, Sazonov DV, Sharlin K, Sundaram B, Totolyan N, Vachova M, Valis M, Bagger M, Häring DA, Ludwig I, Willi R, Zalesak M, Su W, Merschhemke M, Fox EJ. Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study. Mult Scler. 2021 Oct 04;13524585211044479. doi: 10.1177/13524585211044479. Epub 2021 Oct 04. PMID: 34605319.
Copy
Download .nbib